These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19631909)

  • 1. Risk stratification for sudden cardiac death: is there a clinical role for T wave alternans?
    Cutler MJ; Rosenbaum DS
    Heart Rhythm; 2009 Aug; 6(8 Suppl):S56-61. PubMed ID: 19631909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvolt T-wave alternans for the risk stratification of dangerous ventricular arrhythmias in patients with previously implanted automatic cardioverter-defibrillator.
    Lewandowski M; Kossuth I; Zielonka J; Wielusiński M; Kazimierczak A; Kornacewicz Jach Z; Przybycień K; Kaliszczak R
    Kardiol Pol; 2011; 69(6):580-5. PubMed ID: 21678296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of Prognostic Value of T-Wave Alternans for Implantable Cardioverter-Defibrillator Benefit in Primary Prevention.
    Pelli A; Kenttä TV; Junttila MJ; Huber C; Schlögl S; Zabel M; Malik M; Willems R; Vos MA; Harden M; Friede T; Sticherling C; Huikuri HV;
    J Am Heart Assoc; 2024 Jun; 13(11):e032465. PubMed ID: 38804218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?
    Dagres N; Hindricks G
    Eur Heart J; 2013 Jul; 34(26):1964-71. PubMed ID: 23644180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy.
    Gold MR; Ip JH; Costantini O; Poole JE; McNulty S; Mark DB; Lee KL; Bardy GH
    Circulation; 2008 Nov; 118(20):2022-8. PubMed ID: 18955671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of microvolt T-wave alternans testing in scheduling implantable cardioverter-defibrillator placement for the primary prevention of sudden cardiac death in patients with left ventricular dysfunction.
    Daniłowicz-Szymanowicz L; Suchecka J; Zagożdżon P; Szwoch M; Kempa M; Raczak G
    Kardiol Pol; 2015; 73(6):429-36. PubMed ID: 25371309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy.
    Chauhan VS; Selvaraj RJ
    Curr Opin Cardiol; 2007 Jan; 22(1):25-32. PubMed ID: 17143041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification of ventricular arrhythmias in patients with systolic heart failure.
    Vest RN; Gold MR
    Curr Opin Cardiol; 2010 May; 25(3):268-75. PubMed ID: 20224387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Negative result of microvolt T-wave alternans test is helpful in scheduling the order of cardioverter-defibrillator implantation in primary prevention of sudden cardiac death in individuals with the left ventricular systolic dysfunction].
    Daniłowicz-Szymanowicz L; Szwoch M; Raczak J; Raczak G
    Pol Merkur Lekarski; 2012 Oct; 33(196):193-7. PubMed ID: 23272605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
    J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers.
    Hohnloser SH; Klingenheben T; Li YG; Zabel M; Peetermans J; Cohen RJ
    J Cardiovasc Electrophysiol; 1998 Dec; 9(12):1258-68. PubMed ID: 9869525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory ECG-based T-wave alternans monitoring for risk assessment and guiding medical therapy: mechanisms and clinical applications.
    Verrier RL; Ikeda T
    Prog Cardiovasc Dis; 2013; 56(2):172-85. PubMed ID: 24215749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy.
    Disertori M; Quintarelli S; Mazzola S; Favalli V; Narula N; Arbustini E
    Europace; 2013 Dec; 15(12):1693-701. PubMed ID: 23946316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-wave alternans for risk stratification and prevention of sudden cardiac death.
    Pruvot EJ; Rosenbaum DS
    Curr Cardiol Rep; 2003 Sep; 5(5):350-7. PubMed ID: 12917048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.
    Keil L; Chevalier C; Kirchhof P; Blankenberg S; Lund G; Müllerleile K; Magnussen C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
    Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
    Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The problem of indeterminate microvolt T-wave alternans results in patients with left ventricular dysfunction referred for implantable cardioverter-defibrillator implantation in the primary prevention of sudden cardiac death.
    Daniłowicz Szymanowicz L; Szwoch M; Kempa M; Raczak G
    Kardiol Pol; 2012; 70(8):795-802. PubMed ID: 22933211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of microvolt T-wave alternans for predicting outcome in patients with Chagas disease with implantable cardioverter defibrillators.
    Barbosa MPT; da Costa Rocha MO; Neto ES; Brandão FV; Lombardi F; Ribeiro ALP
    Int J Cardiol; 2016 Nov; 222():80-85. PubMed ID: 27467316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
    Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z
    Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.